 We have reached a milestone
in the OHTS! Our findings are published
in the June
issue of Archives of Ophthalmology. Publication of these
two papers is important because now we have proven that eye drop medications
do work to prevent or delay the onset of glaucoma. The rate of developing
glaucoma in OHTS was reduced by 60% in the participants taking eye drops.
In addition, the eye drop treatment did not cause health problems. Without
you and our partnership this study would not have been possible.
Because open-angle glaucoma
affects about 2.2 million Americans age 40 and over you have provided a
public health service that will be felt for generations to come.
There are no words to sufficiently
thank you for your participation and dedication to the study. It can’t be
said enough, without you this study would not have not been possible. With
your continued help we will be able to learn more about how to prevent glaucoma.
Sincerely,
Michael A. Kass, M.D.
|
